Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junhui Zhao

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|July 7, 2019
Attitudes toward Peritoneal Dialysis among Peritoneal Dialysis and Hemodialysis Medical Directors: Are We Preaching to the Right Choir?Jenny I Shen, Martin J Schreiber, Junhui Zhao, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 11, 2019
The Association of Functional Status with Mortality and Dialysis Modality Change: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)Karthik Tennankore, Junhui Zhao, Angelo Karaboyas, et al.
Small Methods|June 3, 2025
Macrophage Vesicles-Loaded NIR-II AIEgens for Precise In Situ Fluorescence Imaging of AtherosclerosisZhiheng Luo, Xipeng Li, Caifa You, et al.
JAMA Network Open|October 5, 2020
Safety, Antitumor Activity, and Pharmacokinetics of Toripalimab, a Programmed Cell Death 1 Inhibitor, in Patients With Advanced Non-Small Cell Lung Cancer: A Phase 1 TrialZhijie Wang, Jianming Ying, Jiachen Xu, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 15, 2022
Assisted peritoneal dialysis performed by caregivers and its association with patient outcomesPongpratch Puapatanakul, Talerngsak Kanjanabuch, Kriang Tungsanga, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 1, 2021
Secondary hyperparathyroidism, weight loss, and longer term mortality in haemodialysis patients: results from the DOPPSHirotaka Komaba, Junhui Zhao, Suguru Yamamoto, et al.
Oncotargets and Therapy|August 26, 2021
Efficacy and Safety of Apatinib for Elderly Patients with Advanced or Metastatic Gastric Cancer After Failure of at Least First-Line Chemotherapy: A Multi-Center, Single-Arm, Phase II StudyDengfeng Ren, Guoxiu Wang, Yu Zhang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 28, 2018
Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the Peritoneal Dialysis Outcomes and Practice Patterns StudyNeil Boudville, David W Johnson, Junhui Zhao, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 31, 2022
Variation in Peritoneal Dialysis Time on Therapy by Country: Results from the Peritoneal Dialysis Outcomes and Practice Patterns StudyMark Lambie, Junhui Zhao, Keith McCullough, et al.
BMC Nephrology|April 4, 2019
Patient-reported advantages and disadvantages of peritoneal dialysis: results from the PDOPPSNidhi Sukul, Junhui Zhao, Douglas S Fuller, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Clinical Journal of the American Society of Nephrology : CJASN|July 7, 2019
Attitudes toward Peritoneal Dialysis among Peritoneal Dialysis and Hemodialysis Medical Directors: Are We Preaching to the Right Choir?Jenny I Shen, Martin J Schreiber, Junhui Zhao, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 11, 2019
The Association of Functional Status with Mortality and Dialysis Modality Change: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)Karthik Tennankore, Junhui Zhao, Angelo Karaboyas, et al.
Small Methods|June 3, 2025
Macrophage Vesicles-Loaded NIR-II AIEgens for Precise In Situ Fluorescence Imaging of AtherosclerosisZhiheng Luo, Xipeng Li, Caifa You, et al.
JAMA Network Open|October 5, 2020
Safety, Antitumor Activity, and Pharmacokinetics of Toripalimab, a Programmed Cell Death 1 Inhibitor, in Patients With Advanced Non-Small Cell Lung Cancer: A Phase 1 TrialZhijie Wang, Jianming Ying, Jiachen Xu, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 15, 2022
Assisted peritoneal dialysis performed by caregivers and its association with patient outcomesPongpratch Puapatanakul, Talerngsak Kanjanabuch, Kriang Tungsanga, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 1, 2021
Secondary hyperparathyroidism, weight loss, and longer term mortality in haemodialysis patients: results from the DOPPSHirotaka Komaba, Junhui Zhao, Suguru Yamamoto, et al.
Oncotargets and Therapy|August 26, 2021
Efficacy and Safety of Apatinib for Elderly Patients with Advanced or Metastatic Gastric Cancer After Failure of at Least First-Line Chemotherapy: A Multi-Center, Single-Arm, Phase II StudyDengfeng Ren, Guoxiu Wang, Yu Zhang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 28, 2018
Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the Peritoneal Dialysis Outcomes and Practice Patterns StudyNeil Boudville, David W Johnson, Junhui Zhao, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 31, 2022
Variation in Peritoneal Dialysis Time on Therapy by Country: Results from the Peritoneal Dialysis Outcomes and Practice Patterns StudyMark Lambie, Junhui Zhao, Keith McCullough, et al.
BMC Nephrology|April 4, 2019
Patient-reported advantages and disadvantages of peritoneal dialysis: results from the PDOPPSNidhi Sukul, Junhui Zhao, Douglas S Fuller, et al.
Pageof 13